CONNECT for Health Act of 2025

1) What happened and its current status: Rep. Mike Thompson (D-CA) introduced HR4206 on June 26, 2025—the CONNECT for Health Act of 2025, a bill to permanently expand Medicare telehealth coverage. The bill was referred to the House Committees on Energy and Commerce and Ways and Means. It is an early-stage authorization bill with no appropriations attached. The identical Senate companion bill S1261 was introduced by Sen. Schatz (D-HI). The bill has 234 cosponsors, a very high number reflecting broad bipartisan support for telehealth expansion following the pandemic-era flexibilities that expired in 2025. The bill is still in committee; no hearings or markups have occurred yet. 2) The money trail: HR4206 is an authorization bill that amends Title XVIII of the Social Security Act to expand Medicare telehealth coverage—it does NOT authorize any specific dollar amount of spending. The financial impact is indirect: by expanding the population eligible for telehealth services (removing geographic restrictions, allowing home as originating site, adding FQHCs, RHCs, and Native American health facilities, and repealing the six-month in-person requirement for telemental health), the bill increases the total addressable market (TAM) for telehealth services within Medicare. The Congressional Budget Office (CBO) would score this bill; historically, telehealth expansion bills have been scored as net savers because virtual care reduces expensive ER visits and inpatient admissions. The mechanism is regulatory relief—CMS must update its telehealth reimbursement rules to cover more services, sites, and practitioners. Companies that provide telehealth platforms or operate virtual care networks will see increased utilization and reimbursement revenue as Medicare beneficiaries gain broader access. 3) Structural winners and losers: Winners are telehealth platform providers ($TDOC, $AMWL) that directly benefit from increased Medicare utilization; integrated payor-provider systems with Medicare Advantage exposure ($UNH, $CVS) that can reduce medical costs by substituting virtual visits for in-person care, particularly for chronic disease management and mental health; and technology/device vendors that supply remote patient monitoring (RPM) and virtual care hardware. Losers include traditional in-person healthcare facilities that may see volume shift to virtual care, particularly urgent care centers and rural clinics that previously had geographic monopolies on Medicare services. No negative tickers are listed because the net effect on the named companies is positive. 4) Real market data analysis: Based on the provided Yahoo Finance data, $TDOC closed at $5.38 on April 30, 2026, down 6.43% over 7 days and down 1.28% over 30 days—trading near the low end of its 52-week range ($4.4–$9.77). $AMWL closed at $5.86, down 0.34% over 7 days but up 11.41% over 30 days. Both stocks react to policy catalysts; the lack of near-term price movement reflects that HR4206 is still in early committee stage. $UNH closed at $363.93, up 2.54% over 7 days and 34.49% over 30 days—strong performance driven by earnings and forward guidance. $CVS closed at $82.86, up 6.31% over 7 days and 15.37% over 30 days, approaching the top of its 52-week range. The 30-day strength in UNH and CVS reflects broader healthcare sector momentum rather than specific telehealth legislation pricing in. 5) Timeline: HR4206 is at the beginning of a long legislative journey. The bill must pass through both House committees (Energy and Commerce, Ways and Means), receive a floor vote in the House, pass the Senate (identical companion S1261 is in Senate Finance), and be signed by the President. Given 234 cosponsors and the Senate companion bill, passage probability within the 119th Congress (which runs through January 2027) is moderate-to-high. The earliest potential enactment is mid-2026. Investors should watch for committee markups and CBO scoring as signals of legislative velocity.